233 related articles for article (PubMed ID: 20848219)
1. Targeting interleukin-21 in rheumatoid arthritis.
Yuan FL; Hu W; Lu WG; Li X; Li JP; Xu RS; Li CW; Chen FH; Jin C
Mol Biol Rep; 2011 Mar; 38(3):1717-21. PubMed ID: 20848219
[TBL] [Abstract][Full Text] [Related]
2. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
Xu WD; Zhang M; Zhang YJ; Ye DQ
Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
4. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.
Jüngel A; Distler JH; Kurowska-Stolarska M; Seemayer CA; Seibl R; Forster A; Michel BA; Gay RE; Emmrich F; Gay S; Distler O
Arthritis Rheum; 2004 May; 50(5):1468-76. PubMed ID: 15146416
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
Li J; Shen W; Kong K; Liu Z
Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
[TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
7. IL-33: a promising therapeutic target for rheumatoid arthritis?
Yuan FL; Li X; Lu WG; Li CW; Xu RS; Dong J
Expert Opin Ther Targets; 2011 May; 15(5):529-34. PubMed ID: 21446881
[TBL] [Abstract][Full Text] [Related]
8. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Andersson AK; Feldmann M; Brennan FM
Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
[TBL] [Abstract][Full Text] [Related]
10. Increased Binding of Specificity Protein 1 to the
Dam EM; Maier AC; Hocking AM; Carlin J; Ng B; Buckner JH
Front Immunol; 2018; 9():1978. PubMed ID: 30233580
[TBL] [Abstract][Full Text] [Related]
11. IL-32 with potential insights into rheumatoid arthritis.
Xu WD; Zhang M; Feng CC; Yang XK; Pan HF; Ye DQ
Clin Immunol; 2013 May; 147(2):89-94. PubMed ID: 23578550
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 Induces Proliferation and Proinflammatory Cytokine Profile of Fibroblast-like Synoviocytes of Patients with Rheumatoid Arthritis.
Xing R; Yang L; Jin Y; Sun L; Li C; Li Z; Zhao J; Liu X
Scand J Immunol; 2016 Jan; 83(1):64-71. PubMed ID: 26482544
[TBL] [Abstract][Full Text] [Related]
13. The cellular source and target of IL-21 in K/BxN autoimmune arthritis.
Block KE; Huang H
J Immunol; 2013 Sep; 191(6):2948-55. PubMed ID: 23960240
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of IL-15 in rheumatoid arthritis.
Yang XK; Xu WD; Leng RX; Liang Y; Liu YY; Fang XY; Feng CC; Li R; Cen H; Pan HF; Ye DQ
Hum Immunol; 2015 Nov; 76(11):812-8. PubMed ID: 26429323
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-23 as a potential therapeutic target for rheumatoid arthritis.
Rong C; Hu W; Wu FR; Cao XJ; Chen FH
Mol Cell Biochem; 2012 Feb; 361(1-2):243-8. PubMed ID: 22012611
[TBL] [Abstract][Full Text] [Related]
16. [Detection of peripheral follicular helper T cells in rheumatoid arthritis].
An LM; Li J; Ji LL; Li GT; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):951-957. PubMed ID: 27987496
[TBL] [Abstract][Full Text] [Related]
17. IL-21 impairs pro-inflammatory activity of M1-like macrophages exerting anti-inflammatory effects on rheumatoid arthritis.
Jian L; Li C; Wang X; Sun L; Ma Z; Zhao J
Autoimmunity; 2022 Mar; 55(2):75-85. PubMed ID: 34842006
[No Abstract] [Full Text] [Related]
18. Interleukin-27 as a potential therapeutic target for rheumatoid arthritis: has the time come?
Gong F; Pan YH; Huang X; Chen J; Xiao JH; Zhu HY
Clin Rheumatol; 2013 Oct; 32(10):1425-8. PubMed ID: 23877489
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
Xie Q; Huang C; Li J
Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
[TBL] [Abstract][Full Text] [Related]
20. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
